Thyroid combination therapy linked to lower dementia and mortality risks
Combination thyroid therapy was associated with lower dementia and mortality risks than levothyroxine alone. This medical-record study cannot establish a treatment benefit.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
Among patients with an underactive thyroid, combination treatment was associated with lower dementia and mortality risks than levothyroxine alone. Matching and statistical adjustment addressed some differences between patients, but these observational comparisons cannot establish that adding another thyroid hormone prevents dementia or extends life. The treatment association needs confirmation in further research.
The abstract omits confidence intervals and atrial fibrillation results. It also leaves unclear how desiccated thyroid extract was classified in the combination-treatment comparison.
What researchers found
Treatment association
Combination therapy versus levothyroxine alone over 20 years of follow-up; both relative-risk and adjusted hazard-ratio analyses favored combination therapy.
Risk compared with controls
Patients with hypothyroidism had higher dementia and mortality risks than controls, including those described as having normal TSH levels. The abstract reports greater risks when TSH levels were outside the target range.
What matching can establish
The researchers matched groups by age, sex and other illnesses to improve comparability. This addresses measured differences, but the abstract does not establish that all relevant differences between treatment groups were accounted for.
The original publication
Treatment of Hypothyroidism That Contains Liothyronine is Associated With Reduced Risk of Dementia and Mortality.
Beltrão FEL, Carvalhal G, Meneghini V et al.
J Clin Endocrinol Metab · 2026
- PubMed ID
- 40579157
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.